Facebook
Twitter
LinkedIn
ForwardAddiction Medicine Review Course 2014
The Review Course consists of 22 lectures presenting an overview of the core elements of addiction medicine, presented by top experts in the field. It can serve as a broad review for clinicians, a review of the basics for newcomers, or a starting point for self-assessment and study for those planning to sit for the American Board of Addiction Medicine Certification Exam. Since it is not designed exclusively for test preparation, some material not likely to be on the test will be included in plenary sessions as part of providing the foundation for informed clinical practice. It was recorded from the live course held September 3-6, 2014.
What people said about the California Society of Addiction Medicine’s Addiction Medicine Review Course 2014
- “Absolutely outstanding in terms of material presented. Found the conference stimulating, motivating and thought provoking. I feel the energy to change and educate the world about this epidemic of addiction that affects all of us.”
- “One of the best conferences ever attended; well organized, excellent and knowledgeable presenters, and friendly staff. It helped me to prepare for the exam and now I feel more confident to take the test.”
Price/Purchase
- ASAM and/or CSAM Members: $495.00
- Non-Member: $695.00
You must register on this site before purchasing using the link on the upper right corner of this page. Only after registering will you see the "Add to Cart" button. To purchase, scroll to the bottom of the page and choose your purchase option (member/non-member) and click "Add to Cart."
Credit
PHYSICIANS: The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 16.5 AMA PRA Category 1 Credits™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of 16.5 AMA/PRA Category 1 Credits™ for completing the Review Course.
Target Audience
- Practicing physicians in both primary care and other specialty fields seeking an introduction to the full spectrum of substance use disorders, their diagnosis, and appropriate management.
- Physicians preparing for the certification examination in addiction medicine requiring an overview of the core elements of addiction medicine in a way that allows them to identify the areas where they may need more study.
- Physicians currently practicing in the field who want a refresher course based on the latest clinical research.
- Other health care professionals, including psychologists, therapists, nurses and drug abuse counselors, who are involved in the treatment of patients with substance use disorders.
Learning Objectives
Upon completion of this course, participants should be able to:
- Recognize the effects of alcohol, tobacco, and other drugs in both tolerant and non-tolerant individuals;
- Understand the basic neurobiological, behavioral, and genetic mechanisms of addiction;
- Describe the main drugs of abuse, their pharmacology, and specifics associated with the diagnosis, detoxification, and treatment for each, and apply in clinical situations
- Apply in treatment an understanding of the main features of related psychological disorders seen in patients suffering from substance abuse disorders.
Additional Information
| Attachment | Size |
|---|---|
 Disclosure Statement | 36.4 KB |
- Sharone Ann Abramowitz, MD, Director, Behavioral & Addiction Medicine, Internal Medicine Residency, Division of Primary Care, Alameda Health System; Motivational Interviewing Network of Trainers; Psychiatry & Addiction Medicine Private Practice, East Bay and San Francisco
- Anthony P. Albanese, MD, FASAM, Chief of Hepatology, Northern California VA Healthcare System, Clinical Professor of Medicine & Psychiatry UC Davis
- Peter Banys, MD, MSc, Clinical Professor of Psychiatry, UC San Francisco
- Timmen L. Cermak, MD, Psychiatrist in private practice, Mill Valley
- Nancy Goler, MD, Regional Medical Director: Early Start Program Department of Obstetrics and Gynecology; Kaiser Permanente Vallejo Medical Center
- Douglas Gourlay, MD, Educational Consultant, Pain and Chemical Dependency Division of the Wasser Pain Management Centre at Mount Sinai Hospital, Toronto
- David Y Kan, MD, Medical Director, Opioid Replacement Team and Associate Chief for Mental Health Services for QI/QA, Veterans Administration Medical Center, San Francisco
- John Kelly, PhD, Program Director of the Addiction Recovery Management Service and Associate Director of the Center for Addiction Medicine, Massachusetts General Hospital; Associate Professor, Harvard Medical School
- George Koob, PhD, Director, National Institute on Alcohol Abuse and Alcoholism
- Thomas R. Kosten, MD, JH Waggoner Professor of Psychiatry and Co-Director, Institute for Clinical and Translational Research, Baylor College of Medicine, Houston
- Paula J. Lum, MD, MPH, Associate Professor of Clinical Medicine, Division of HIV/AIDS, Department of Medicine, UC San Francisco
- Judith A. Martin, MD, FASAM, Medical Director of Substance Abuse Services, Dept. of Public Health, City & County of San Francisco
- Mitchell Nides, PhD, President, Los Angeles Clinical Trials; Director, Picture Quitting, the Entertainment Industry's Quit Smoking Program
- Kent Olson, MD, Medical Director, San Francisco Division California Poison Control System; Clinical Professor of Medicine & Pharmacy, UC San Francisco
- Richard K. Ries, MD, FASAM, Professor of Psychiatry and Director of Addictions Division, University of Washington Medical School
- Deborah Simkin, MD, Clinical Assistant Professor, Department of Psychiatry, University of Emory School of Medicine
- Silas Wheelock Smith, MD, Assistant Professor and Section Chief Quality, Safety, and Practice Innovation, Department of Emergency Medicine, NYU School of Medicine; Associate Director, Fellowship in Medical Toxicology, New York City Poison Control Center
Available Credit
- 16.50 AMA Category 1